FDA: Ignore the false racial equity argument for keeping Makena
A pharma company is arguing that Makena should be kept on the market because it may work in Black people. But it doesn't work in any people.
Source: statnews.com
Stay updated with breaking news from Optimizing Neonatal Gestation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A pharma company is arguing that Makena should be kept on the market because it may work in Black people. But it doesn't work in any people.